The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOracle Power Regulatory News (ORCP)

Share Price Information for Oracle Power (ORCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.03
Bid: 0.028
Ask: 0.032
Change: 0.00 (0.00%)
Spread: 0.004 (14.286%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.03
ORCP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Equity Placing & Exercise Of Warrants

28 Dec 2017 07:00

RNS Number : 3986A
Oracle Power PLC
28 December 2017
 

 28 December 2017

Oracle Power PLC

("Oracle" or "the Company")

 

 

Equity Placing at 2.3p per Ordinary Share

Exercise of Warrants

 

Oracle Power PLC (AIM:ORCP), the UK energy developer of a combined lignite coal mine and mine mouth power plant located in the south-eastern Sindh Province of Pakistan, announces that it has issued a total of 27,023,652 ordinary shares of 0.1 pence each in the capital of the Company ("Ordinary Shares") at a price of 2.3 pence per share, representing an approximate premium of 20% to the closing mid-market price on 27 December 2017, pursuant to an equity fundraising. In addition, the Company also announces that Brandon Hill Capital Limited ("Brandon Hill"), the Company's broker, has exercised warrants held over 23,076,920 Ordinary Shares.

 

Equity placing and warrant exercise

The Company has raised £621,544 before costs by way of a placing of 27,023,652 new Ordinary Shares at a price of 2.3p per Ordinary Share to a new investor and the Company's joint broker, Brandon Hill, (the "Placing").

 

In addition, Brandon Hill has also exercised warrants held over 23,076,920 Ordinary Shares, at an exercise price of 0.65 pence per Ordinary Share (the "Exercise Price"), resulting in gross proceeds of £150,000 being receivable by the Company (the "Warrant Exercise"). The warrants were issued to Brandon Hill on 2 March 2015 at the Exercise Price, as remuneration for its role in a placing for the Company at that time. These warrants were due to expire in Q1 2018.

 

The proceeds of the Placing and the Warrant Exercise will provide Oracle with funds to repay the drawn principal and outstanding interest balance on the loan facility made available by Brandon Hill (announced on 25 September 2017) of £471,544, and will provide general working capital as the Company looks to move towards financial close on the basis of the Memorandum of Understanding with two major Chinese State Owned Enterprises, announced on 21 November 2017.

 

As part of the Placing, Brandon Hill has agreed to subscribe for 13,980,174 Ordinary Shares. Following the issue of the Ordinary Shares pursuant to the Placing and Warrant Exercise, Brandon Hill, together with its parent company, Optima Worldwide Group PLC, will hold 161,424,312 Ordinary Shares, representing 16.78 per cent of the enlarged issued share capital of the Company.

 

Related party transaction

Brandon Hill, in aggregate with its parent company, Optima Worldwide Group PLC, is a substantial shareholder of the Company. Accordingly, Brandon Hill's participation in the Placing constitutes a related party transaction pursuant to Rule 13 of the AIM Rules for Companies. The directors of the Company consider, having consulted with the Company's nominated adviser, Grant Thornton UK LLP, that the terms of this transaction are fair and reasonable insofar as its shareholders are concerned.

 

 Shahrukh Khan, CEO of Oracle, said:

 "We are pleased to announce the equity placing at a healthy premium to the current market share price, which will allow us to repay the outstanding loan balance to Brandon Hill and will strengthen the Company's balance sheet as we move into 2018 and ahead of targeting financial close."

 

 

Settlement and dealings

Application will be made for the 50,100,572 Ordinary Shares, issued pursuant to the Warrant Exercise and Placing, which will rank pari passu with the Company's existing issued Ordinary Shares, to be admitted to trading on AIM. Dealings on AIM are expected to commence at 8:00am on or around 5 January 2018 ("Admission").

 

Following Admission, for the purposes of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules ("DTRs"), Oracle will have 961,883,698 Ordinary Shares in issue with voting rights attached (one vote per Ordinary Share). The Company does not hold any shares in treasury. This figure of 961,883,698 ordinary shares may be used by the Company's shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the DTRs.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

For further information please contact:

 

Oracle Power PLC

Shahrukh Khan

 

+44 (0) 203 580 4314

Brandon Hill Capital Limited

Oliver Stansfield

 

+44 (0)203 463 5000

Peterhouse Corporate Finance

Charles Goodfellow

 

+44 (0) 207 220 9791

Grant Thornton UK LLP

Salmaan Khawaja, Richard Tonthat, Daniel Bush 

 

+44 (0) 207 383 5100

Blytheweigh

Tim Blythe, Camilla Horsfall, Megan Ray

 

+44 (0) 207 138 3204

Fortbridge Consulting

Matt Beale, Bill Kemmery

+44 (0)7966 389196

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEFEFEFWFWSELE
Date   Source Headline
9th Sep 202010:30 amRNSConversion Notice and Issue of Equity
8th Sep 20202:03 pmRNSPPIB Meeting with Consortium Scheduled
7th Sep 20204:08 pmRNSHolding(s) in Company
4th Sep 20206:27 pmRNSHolding(s) in Company
1st Sep 202011:18 amRNSConversion Notice and Issue of Equity
28th Aug 20202:06 pmRNSSecond Price Monitoring Extn
28th Aug 20202:00 pmRNSPrice Monitoring Extension
28th Aug 202012:30 pmRNSConsortium invited to meet with PPIB re LOI
17th Aug 20207:00 amRNSConversion Notice and Issue of Equity
29th Jul 20207:00 amRNSNon- Binding MoU signed with HH Private Office
21st Jul 20207:42 amRNSShareholder Q&A Recording
17th Jul 20204:15 pmRNSAGM 2020 Q&A
16th Jul 20204:15 pmRNSResult of AGM
14th Jul 20207:00 amRNSLOI Payment
13th Jul 20207:00 amRNSShareholder Q&A Session
9th Jul 20207:00 amRNSSubscription & Financing Facility
7th Jul 20204:45 pmRNSHolding(s) in Company
7th Jul 20201:15 pmRNSHolding(s) in Company
2nd Jul 20207:00 amRNSExercise of Warrants
29th Jun 20201:15 pmRNSExercise of Warrants
26th Jun 20203:00 pmRNSExercise of warrants and issue of equity
23rd Jun 20205:56 pmRNSNotice of AGM
23rd Jun 20207:00 amRNSFinal Results
22nd Jun 20209:06 amRNSSecond Price Monitoring Extn
22nd Jun 20209:00 amRNSPrice Monitoring Extension
4th Jun 20207:00 amRNSLOI Payment & Related Party Transaction
7th May 20204:45 pmRNSHolding(s) in Company
4th May 20204:00 pmRNSHolding(s) in Company
9th Apr 202012:30 pmRNSConference Call Highlights
7th Apr 202011:05 amRNSSecond Price Monitoring Extn
7th Apr 202011:00 amRNSPrice Monitoring Extension
3rd Apr 20209:00 amRNSQ1 2020 Update from the CEO
3rd Apr 20207:00 amRNSInvestor Engagement
27th Mar 20204:42 pmRNSSecond Price Monitoring Extn
27th Mar 20204:36 pmRNSPrice Monitoring Extension
18th Mar 20209:30 amRNSBoard Appointment
12th Mar 20203:15 pmRNSExercise of warrants and issue of equity
11th Mar 20207:00 amRNSSupport for Development of Thar Block VI
5th Mar 202012:15 pmRNSHolding(s) in Company
27th Feb 20204:09 pmRNSExercise of Warrants and Issue of Equity
26th Feb 20204:41 pmRNSSecond Price Monitoring Extn
26th Feb 20204:35 pmRNSPrice Monitoring Extension
25th Feb 20207:00 amRNSThar Block VI Developments
19th Feb 20204:41 pmRNSSecond Price Monitoring Extn
19th Feb 20204:35 pmRNSPrice Monitoring Extension
19th Feb 202011:15 amRNSConsortium Agreement
3rd Feb 20207:00 amRNSLock-In Agreement
31st Jan 202010:15 amRNSExercise of warrants and issue of equity
20th Jan 20202:15 pmRNSExercise of warrants and issue of equity
15th Jan 20201:45 pmRNSExercise of warrants and issue of equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.